News Jan 03, 2025
Porton Achieves Higher Scores in the 2024 S & P Global ESG Assessment
Porton Pharma Solutions Ltd. (hereinafter “Porton”) is glad to announce that it scored 44 (out of 100) in the 2024 S&P Global Corporate Sustainability Assessment reflecting an improvement of 6 points over the previous assessment, where scores in all the three dimensions getting improved. (CSA Score as of 27/11/2024).
News Dec 23, 2024
Porton Pharma Solutions and Dragon Sail Pharmaceutical Form Strategic Partnership
On December 20, 2024, Porton Pharma Solutions Ltd. (hereinafter referred to as “Porton Pharma Solutions” or “Porton”) and Dragon Sail Pharmaceutical (Shanghai) Co., Ltd. (a subsidiary of Guilin Sanjin, hereinafter referred to as “Dragon Sail Pharmaceutical”) formally signed a strategic cooperation agreement in Guilin, southern of China.
NewslettersDec 19, 2024
Porton Newsletter | Q4 2024 Recap
Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian Porton Successfully Hosts Ceremony for New Modality Capacity Upgrade Drug Modalities: Innovative Services & Solutions from Porton Pharma
News Dec 11, 2024
Porton and Aojin Collaborate to Advance XDC Drugs for Dual INDs
Recently, Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co., Ltd. ("Aojin Life Sciences").
News Dec 06, 2024
Porton Recognized as an Exemplary Case for Sustainable Development
Porton was recently selected as a "2024 Exemplary Case for Sustainable Development Among Chinese Listed Companies" by the China Association of Public Companies.
News Dec 06, 2024
Porton is thrilled to announce the launch of its newly redesigned official website
With a Focus on Globalization, Innovative Technology Platforms, and Accelerating Your New Business Opportunities into the Clinic and to the Market.
News Nov 13, 2024
Porton Has Been Invited to the China–Slovenia Business and Investment Forum
During the Slovenian government delegation's visit to Shanghai, the Slovenian Consulate in Shanghai and the Shanghai Municipal Commission for Trade Promotion hosted the "China–Slovenia Business and Investment Forum" on November 4th, 2024.
News Nov 09, 2024
Porton’s New Modality Capacity Upgrade Ceremony Successfully Held
On November 7, 2024, the New Modality Capacity Upgrade Ceremony was successfully held in Fengxian, Shanghai, China. Attendees included Mr. Weng Jun，Vice General Manager，Shanghai Hangzhou Bay Economic & Technological Development Co., Ltd., Mr. Bai Yinchun, COO and Senior Vice President of Porton, Ms. Pi Wei, Vice President and Board Secretary of Porton, Ms. Meng Fan, Deputy General Manager of the Sales & Marketing Center of Porton, and Mr. Xie Lihua, Head of the Synthetic Macromolecules Service Department. Together, they witnessed this significant moment of enhancing the production capacity for new modalities at the Fengxian site.
News Oct 31, 2024
Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities
Porton Pharma has made a major breakthrough in capacity at its GMP manufacturing facility in Fengxian, Shanghai, enhancing its production capabilities significantly.
